Genagon Therapeutics' Seed VC Round

Genagon Therapeutics raised a round of funding on January 26, 2016. Investors include Almi Invest.

Genagon Therapeutics is developing an entirely new, unique approach to treating cancer. Genagon's drug development is based on ground-breaking discoveries in inflammatory signaling active on tumor inf…

Articles about Genagon Therapeutics' Seed VC Round: